Chronic Endometritis and IVF: Silent Inflammation, Biopsy & Treatment
Key Takeaways
Chronic endometritis is a persistent, low-grade inflammation of the uterine lining. It differs from acute endometritis: symptoms may be mild or absent, yet the endometrium may still be less favorable for implantation. Diagnosis usually needs endometrial biopsy with plasma-cell (often CD138) staining — not ultrasound alone.
Key evidence: ESHRE Good Practice Recommendations on Recurrent Implantation Failure Wei et al. 2026 — antibiotic cure and subsequent FET outcomes
On this page
- Why it matters in IVF
- Why it is easy to miss
- How chronic endometritis is diagnosed
- When it is usually investigated
- Treatment for chronic endometritis
- How successful is antibiotic treatment?
- What treatment does — and does not — promise
When silent lining inflammation matters for IVF
Chronic endometritis is a low-grade, persistent inflammation of the uterine lining. It differs from acute endometritis, which is a more abrupt pelvic infection. In the chronic form, immune cells — especially plasma cells — linger in the endometrium. Symptoms may be absent, yet the lining may still be less receptive for implantation.
That silence is why the diagnosis is easy to miss on a routine scan. Ultrasound alone rarely proves it. Confirmation usually needs an endometrial biopsy with plasma-cell staining (often CD138), sometimes after hysteroscopy when the cavity looks uneven or when implantation has failed more than once.
This is why the diagnosis appears in discussions of recurrent implantation failure, recurrent miscarriage, or unexplained infertility. Couples travelling for IVF abroad should bring prior biopsy or hysteroscopy reports when available, so the receiving clinic can decide whether further cavity assessment is needed before transfer.
Why it matters in IVF
Short Answer:
Confirmed chronic endometritis is linked with poorer reproductive outcomes in selected groups, especially after repeated IVF failure — but it doesn’t explain every failed cycle and isn’t a reason to screen every patient automatically.
Chronic inflammation may alter local immune signalling and the surface of the lining in ways that interfere with implantation or early placental development. That pattern shows up repeatedly in the literature: confirmed cases tend to cluster with poorer outcomes, particularly in patients who have already been through more than one failed cycle.
Not every failed IVF cycle is caused by this diagnosis. Not every patient should be screened automatically. When the clinical history raises concern, it becomes a relevant piece of reproductive medicine to evaluate — alongside embryo quality, timing, and other cavity findings.
Why it is easy to miss
Short Answer:
Chronic endometritis often causes no symptoms, or only nonspecific ones like irregular bleeding or discharge that overlap with normal cycle changes, so symptoms alone can’t confirm or rule it out.
Many patients have no clear symptoms. Others may notice:
- irregular bleeding,
- spotting,
- pelvic discomfort,
- unusual discharge.
None of it is specific enough to rely on — plenty of benign cycle changes look much the same, which means symptoms alone can’t confirm or rule out the diagnosis.
Acute endometritis, by contrast, more often presents with fever, marked pain, or recent instrumentation — a different clinical urgency.
How chronic endometritis is diagnosed
Short Answer:
Diagnosis relies on endometrial biopsy with plasma-cell (CD138) staining, sometimes guided by hysteroscopy — not on ultrasound, which isn’t sensitive enough to detect this microscopic inflammation.
Common tools:
| Tool | Role |
|---|---|
| Hysteroscopy | May show micropolyps, focal hyperemia, or stromal edema — clues, not proof |
| Endometrial biopsy | Tissue from the uterine cavity for histology |
| CD138 staining | Highlights plasma cells; used widely to support the diagnosis |
| Culture / microbiology | Sometimes added; practice varies by centre |
A biopsy-based approach is generally more reliable than symptoms or imaging alone. Ultrasound can miss chronic endometritis entirely, and there’s a reason for that: the inflammation is microscopic — plasma cells infiltrating the stromal tissue — sitting below what a standard transvaginal scan can resolve. There’s no telltale sonographic sign to look for, and the endometrium can look completely normal in thickness and texture even when inflammation is confirmed on biopsy. That’s the reason CD138-stained tissue sampling remains the diagnostic standard, not imaging.
When it is usually investigated
Short Answer:
Evaluation is more likely after recurrent implantation failure, recurrent pregnancy loss, or unexplained infertility — not as routine screening for every first-time IVF patient.
Clinicians are more likely to evaluate when there is:
- recurrent implantation failure,
- recurrent pregnancy loss,
- unexplained infertility after a structured workup,
- suspicious hysteroscopic findings inside the cavity.
Routine testing in every first IVF patient remains controversial. The value of screening depends on history, prior transfers, and what else has already been checked. See also hysteroscopy in female infertility.
Treatment for chronic endometritis
Short Answer:
Confirmed chronic endometritis is usually treated with antibiotics chosen by local protocol and culture data, followed by a repeat biopsy (“test of cure”) to check the inflammation has actually cleared before the next transfer.
When the diagnosis is confirmed, treatment often includes antibiotics chosen according to local protocols, culture data when available, and clinical history. Some teams use a combination regimen; others tailor therapy to microbiology.
Many patients undergo a test of cure — a repeat biopsy after treatment — to check whether plasma-cell inflammation has cleared before the next transfer.
Treatment should follow a real diagnosis. Empiric antibiotics for every failed cycle, without biopsy confirmation, are a weaker strategy and can add unnecessary medication.
How Successful Is Antibiotic Treatment?
Short Answer:
One course of oral antibiotics clears chronic endometritis in roughly 81% of cases confirmed by repeat biopsy, and those who clear it have significantly better live birth and pregnancy rates than those whose inflammation persists.
A large retrospective cohort of 2,555 frozen-thawed embryo transfer cycles gives a useful benchmark here. Among women diagnosed with chronic endometritis, one course of oral antibiotics cleared the inflammation — confirmed on repeat biopsy — in roughly 81% of cases (309 of 383) (Wei et al., 2026). Those who cleared went on to have significantly higher live birth and clinical pregnancy rates in their next FET cycle than those whose inflammation persisted. It’s a good illustration of why the “test of cure” biopsy matters: it tells you who actually cleared the inflammation and is more likely to benefit from the next transfer. That said, embryo quality, age, and other uterine factors still shape the outcome — clearing the infection removes one obstacle, not a guarantee.
Dr Aksoy’s clinical perspective
“After one course of antibiotics, chronic endometritis findings clear in roughly 80% of patients. That’s a good rate — but it isn’t enough for us to assume you’re one of them. In roughly one in five patients, inflammation can persist, and we usually can’t tell from discharge, pain, or any other symptom.
“That’s why, especially with a patient who has recurrent implantation failure or a limited number of valuable embryos, I explain the control biopsy this way: I want to see that the lining has actually responded to treatment before transfer. I’m not suggesting the repeat biopsy because I think the antibiotic didn’t work — I’m suggesting it because I don’t want to base the transfer on an assumption. It can mean a brief inconvenience, but it gives us something concrete about whether treatment is actually complete.
“I’m also careful to explain that the roughly 81% figure is a histological cure rate — not a pregnancy or live birth rate. Clearing CD138-positive plasma cells after treatment doesn’t guarantee that an embryo will implant. In my reading of the literature, cure rates across different antibiotic regimens after a single course tend to fall in a similar range, broadly 78–85%, though studies still vary in where the diagnostic threshold is set and in how much treatment actually contributes to reproductive outcomes.
“Two practices bother me here. The first is moving straight to transfer after saying ‘you took the antibiotics, so it must be cleared’ without any confirmation. The second is repeating antibiotic course after course when positivity persists, without asking why. In that situation, I go back and review how the original diagnosis was made, the timing of the biopsy, the CD138 assessment, and whether there’s a polyp, adhesion, or another focus inside the cavity that hasn’t been addressed.
“My summary line in clinic is this: finishing a course of antibiotics is not, to me, the same as finishing treatment. Especially before a transfer, I want to confirm, where possible, that the endometritis has actually resolved — but I also don’t treat the control biopsy as an automatic formality for everyone. It’s an individual decision, based on that patient’s history and the value of the embryo at stake.”
What treatment does — and does not — promise
Short Answer:
Clearing confirmed chronic endometritis may improve the chance of implantation, but it doesn’t guarantee pregnancy — embryo genetics, age, and other uterine factors still matter.
In selected patients, clearing the infection does appear to raise the odds of a successful implantation. What it doesn’t do is guarantee a pregnancy — plenty else still has to align, from embryo genetics and age to sperm factors and the rest of the uterine picture.
If transfers continue to fail after a documented cure, the team widens the review again rather than repeating the same antibiotic course indefinitely. See failed IVF: what to review next.
Request a Case Review
If you’ve had a failed transfer and are wondering whether chronic endometritis or another cavity finding is relevant to your case, a structured review of your biopsy, hysteroscopy, and transfer history is a more useful starting point than another empiric antibiotic course. You can request a confidential case review to have your file assessed before deciding on next steps.
Related reading
- ERA Test in IVF: When It Helps and Why It Is Controversial
- Hysteroscopy in Female Infertility: When It Helps and When It Is Not Routine
- Unexplained infertility: what the diagnosis means
FAQ
Can chronic endometritis be found on ultrasound alone?
Usually not reliably. Ultrasound may raise suspicion in some cases, but diagnosis generally depends on endometrial sampling, often with biopsy and CD138 staining.
Should every IVF patient be tested for chronic endometritis?
No. Routine screening in every patient remains controversial. Evaluation is usually more relevant after repeated implantation failure, recurrent pregnancy loss, unexplained infertility, or suspicious cavity findings.
If chronic endometritis is treated, does IVF success always improve?
Not automatically. Treatment may help when the diagnosis is real and clinically relevant, but it does not explain every failed transfer and should not be framed as a universal fix.
How is chronic endometritis different from acute endometritis?
Acute disease is typically a more abrupt infectious picture. Chronic endometritis is low-grade and often silent, diagnosed by plasma cells in the lining rather than by fever alone.
Do I need antibiotics before every embryo transfer “just in case”?
Not as a default. Antibiotics make more sense after a confirmed diagnosis (and often after documenting clearance), not as a ritual before every transfer.
Sources
- Review: Chronic endometritis and its effect on reproduction (Kimura et al.)
- ESHRE Good Practice Recommendations on Recurrent Implantation Failure
- StatPearls: Endometritis
- Wei L, Zhang Y, Wang S, Xu S, Hu W. Association of cured chronic endometritis after antibiotic treatment with outcomes of the subsequent frozen-thawed embryo transfer cycle among women with first implantation failure: a retrospective cohort study. BMC Pregnancy Childbirth 2026;26(1).
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.